A good technology is not yet an investment opportunity
A good technology is not yet an investment opportunity.
This distinction has become increasingly important to me through years of working around industry, investment, and technology.
A technology may be scientifically validated. It may have a working prototype. It may even have reached the pilot stage.
And yet, an industrial investor may still be unable to make a rational investment decision.
Why? Because the investor is evaluating something broader than whether the technology works.
Can it be scaled reliably?
What happens to unit economics at industrial scale?
Which technical assumptions remain unverified?
Is there a defensible market?
How should intellectual property, execution risk, governance, and accountability be structured?
Who will actually take the technology from a successful pilot to a functioning industrial operation?
These are not secondary questions. They sit at the boundary between scientific validation and industrial investment.
I have become increasingly interested in this boundary because I believe we often treat it as a financing problem. It may actually be an architecture problem.
Capital is looking for investable opportunities. Scientists are developing valuable technologies. Industry is looking for better solutions. Yet something is often missing between them.
Over the coming months, I will share some of my thinking on this gap: what makes a validated technology ready for an industrial investment decision, where current commercialization approaches fall short, and what kind of institutional architecture may be needed between science, industry, and capital.
I am particularly interested in hearing from investors, scientists, and industrial executives who have encountered this gap from different sides.
Where, in your experience, does a promising technology most often become stuck?